Avidity Biosciences (RNA)
(Real Time Quote from BATS)
$25.55 USD
+2.11 (8.98%)
Updated Apr 23, 2024 11:06 AM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.81 |
EPS Last Quarter | -0.79 |
Last EPS Surprise | -46.30% |
ABR | 1.14 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.07 |
Next Year | -3.79 |
EPS (TTM) | -2.90 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.09M | 7.09M | 28.37M | 28.37M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 7.09M | 7.09M | 28.37M | 28.37M |
Low Estimate | 7.09M | 7.09M | 28.37M | 28.37M |
Year ago Sales | 2.23M | 2.32M | 9.56M | 28.37M |
Year over Year Growth Est. | 217.94% | 205.60% | 196.76% | 0.00% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.81 | -0.76 | -3.07 | -3.79 |
# of Estimates | 3 | 2 | 5 | 3 |
Most Recent Consensus | -0.74 | -0.80 | -2.81 | -3.72 |
High Estimate | -0.70 | -0.71 | -2.22 | -2.99 |
Low Estimate | -0.95 | -0.80 | -4.19 | -4.65 |
Year ago EPS | -0.74 | -0.66 | -2.91 | -3.07 |
Year over Year Growth Est. | -9.46% | -15.15% | -5.50% | -23.28% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.81 | -0.76 | -3.07 | -3.79 |
7 Days Ago | -0.81 | -0.76 | -3.07 | -3.79 |
30 Days Ago | -0.81 | -0.76 | -3.07 | -3.79 |
60 Days Ago | -0.80 | -0.84 | -3.49 | -3.55 |
90 Days Ago | -0.80 | -0.84 | -3.49 | -3.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.81 | -0.76 | -3.07 | -3.79 |
Zacks Consensus Estimate | -0.81 | -0.76 | -3.07 | -3.79 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.79 | -0.71 | -0.66 | -0.74 | NA |
Estimate | -0.54 | -0.76 | -0.84 | -0.90 | NA |
Difference | -0.25 | 0.05 | 0.18 | 0.16 | 0.04 |
Surprise | -46.30% | 6.58% | 21.43% | 17.78% | -0.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more